Drug conjugates for BCSFB transport into the CNS
Cerentry's proprietary brain shuttle is designed to enable transport of systemically administered therapeutics across the blood-cerebrospinal fluid barrier, delivering drugs into the ventricles for broader central nervous system access where conventional blood-brain barrier strategies remain limited.